Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.
Infectious Disease Therapeutics Market Forecast: What Value Will The Market Reach By 2030?
The infectious disease therapeutics market has experienced significant expansion recently. Projections indicate it will expand from $150.6 billion in 2025 to $160.84 billion by 2026, achieving a compound annual growth rate (CAGR) of 6.8%. Historically, this growth has been driven by factors such as the substantial global impact of infectious diseases, the broad application of antibiotics and antivirals, governmental immunization initiatives, an increase in pharmaceutical manufacturing capabilities, and enhanced investment in infectious disease research.
The infectious disease therapeutics market is projected to experience robust expansion over the coming years. This market is anticipated to reach a valuation of $200.87 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 5.7%. Several factors will drive this growth during the projected period, including escalating antimicrobial resistance rates, the increasing frequency of infectious disease outbreaks, broadened global vaccination coverage, a rising demand for novel antiviral therapies, and stronger public health preparedness initiatives. Key trends expected during this forecast span encompass a heightened emphasis on antimicrobial resistance management, the accelerating development of broad-spectrum therapeutics, a greater adoption of combination drug therapies, the expansion of rapid-response therapeutics for outbreaks, and augmented investment in vaccine research and stockpiling.
Get A Free Sample Report With In-Depth Market Insights:
Infectious Disease Therapeutics Market Growth Catalysts And Demand Drivers
The increasing incidence of infectious diseases is anticipated to propel the growth of the infectious disease therapeutics market going forward. Infectious diseases are conditions caused by pathogenic microorganisms such as bacteria, viruses, fungi, parasites, or prions. The rise in these diseases is attributed to several significant factors including climate change and environmental disruption, antimicrobial resistance, weakened immune systems, increased interactions with animals, and ecological disturbances. Infectious disease therapeutics are vital for treating infections, reducing morbidity and mortality, and controlling the spread of communicable diseases within communities and across populations. For instance, in October 2023, the National Health Service (NHS) England, a UK-based government department, indicated that in 2022/23, hospitals recorded 147,285 admissions primarily diagnosed as urinary tract infection (UTI). Patients over 65 years of age constituted 56% of these cases, amounting to 82,392 admissions. The 80–84 age group had the highest number of admissions, with 17,280 cases. Therefore, the expanding prevalence of infectious diseases is a driving force for the infectious disease therapeutics market.
Infectious Disease Therapeutics Market Segment Analysis And Revenue Potential
The infectious disease therapeutics market covered in this report is segmented –
1) By Type: Drugs, Vaccines
2) By Disease: Tuberculosis, HIV/AIDS, Influenza, Hepatitis, Other Diseases
3) By End-User: Hospitals And Clinics, Retail Pharmacies, Research Organizations, Other End Users
Subsegments:
1) By Drugs: Antibiotics, Antivirals, Antifungals, Antiparasitics, Other Therapeutic Drugs (Monoclonal Antibodies, Immunomodulators)
2) By Vaccines: Inactivated Vaccines, Live Attenuated Vaccines, Subunit Vaccines, Mrna Vaccines, Dna Vaccines, Toxoid Vaccines
Infectious Disease Therapeutics Market Trends Shaping Long-Term Demand
Leading companies active in the infectious disease therapeutics market are concentrating on integrating multispecific antibody platforms, such as the multispecific therapeutic antibody reactor (MSTAR), to heighten effectiveness, extend protective reach, and fortify responsiveness to emerging viral threats. The multispecific therapeutic antibody reactor (MSTAR) is an advanced multispecific antibody technology that merges several independent binding regions into a single therapeutic molecule, enabling capabilities like broad viral neutralization, the simultaneous targeting of multiple epitopes, and quick adaptation to new variants. For instance, in September 2023, ModeX Therapeutics Inc, a US-based clinical stage biopharmaceutical company, was awarded a contract from the Biomedical Advanced Research and Development Authority to advance its multispecific antibody candidates. These candidates are engineered for the treatment and prevention of viral infectious diseases, including COVID 19 and influenza, demonstrating broad activity against circulating viral strains, potential compatibility with gene based delivery utilizing mRNA or DNA vectors, and a multi binding site architecture. This multispecific antibody strategy enhances therapeutic results by shortening development periods, broadening protective coverage, and lessening the complexity linked with combination biologic treatments.
Infectious Disease Therapeutics Market Key Players Shaping Industry Direction
Major companies operating in the infectious disease therapeutics market are Pfizer Inc., F. Hoffmann-La Roche AG, Merck & Co. Inc., Sanofi SA, AstraZeneca, Novartis International AG, GlaxoSmithKline plc, Gilead Sciences Inc., Janssen Pharmaceuticals, Moderna Inc., Regeneron Pharmaceuticals Inc., Boehringer Ingelheim GmbH, BioCryst Pharmaceuticals Inc.
View The Full Infectious Disease Therapeutics Market Report:
Infectious Disease Therapeutics Market Regional Analysis And Top Geography
North America was the largest region in the infectious disease therapeutics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the infectious disease therapeutics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Leave a Reply